Reply to T. Suemasu et al-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to T. Suemasu et al

Published:2021-09-10 Issue:26 Volume:39 Page:2966-2968
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Eriksson Mikael¹^ORCID,Czene Kamila¹,Hall Per¹^ORCID

Affiliation:

1. Mikael Eriksson, PhD, Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Kamila Czene, PhD, Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; and Per Hall, PhD, MD, Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Oncology, Södersjukhuset, Stockholm, Sweden

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01166

Reference8 articles.

1. Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial

2. Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women

3. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

4. Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP